Thai Red Cross AIDS Research Centre (TRC-ARC) CRS (Site # 31802)

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Hepatitis B1 trial
• Tuberculosis1 trial

Phase

• Phase 1/21 trial
• Phase 21 trial

Status

• Completed1 trial
• Withdrawn1 trial

Lead sponsor

• National Institute of Allergy and Infectious Diseases (NIAID)2 trials

Closed trials

• Completed

  Pharmacokinetics and Safety of Double-dose Dolutegravir When Used With Rifapentine for HIV-associated Tuberculosis

  NCT05630872· Phase 2· National Institute of Allergy and Infectious Diseases (NIAID)· Source

• Withdrawn

  Safety and Immunotherapeutic Activity of Cemiplimab in Participants With HBV on Suppressive Antiviral Therapy

  NCT04046107· Phase 1/2· National Institute of Allergy and Infectious Diseases (NIAID)· Source